Testing the Addition of an Anti-cancer Drug, Entinostat, to the Usual Chemotherapy and Immunotherapy Treatment (Atezolizumab, Carboplatin and Etoposide) for Previously Untreated Aggressive Lung Cancer That Has Spread
Clinical trial NCT04631029 · COMPLETED
Trial details
- NCT number
- NCT04631029
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-27
- Primary completion
- 2021-12-30
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.